SCHEMBL6154708

SCHEMBL6154708

Nc1cccc(SCc2ccc(-c3ccccc3)cc2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 5/20 0.50
TAAR1 Q96RJ0 2/20 0.46
CYP3A4 P08684 3/20 0.44
SLC6A4 P31645 1/20 0.44
CYP17A1 P05093 1/20 0.44
CYP19A1 P11511 1/20 0.44
CYP11B1 P15538 1/20 0.44
CYP11B2 P19099 1/20 0.44
MAOB P27338 4/20 0.42
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
KMT2A Q03164 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
POLB P06746 1/20 0.41
DHFR P00374 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
DAO P14920 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL6679866 0.98 MAOA (0.48) MAOATAAR1CYP3A4SLC6A4CYP17A1
SCHEMBL1323306 0.90 MAOB (0.52) MAOACYP3A4SLC6A4MAOBNPC1
SCHEMBL31441986 0.90 MAOB (0.52) MAOACYP3A4SLC6A4MAOBNPC1
SCHEMBL6679870 0.83 MAPT (0.43) MAOATAAR1CYP3A4SLC6A4MAOB
SCHEMBL6154702 0.81 MAOA (0.42) MAOATAAR1CYP3A4SLC6A4MAOB
SCHEMBL20132015 0.81 RAB9A (0.50) SLC6A4CYP19A1NPC1RAB9AMEN1
SCHEMBL5391138 0.81 ALDH1A1 (0.62) MAOATAAR1CYP3A4SLC6A4MAOB
SCHEMBL19973146 0.80 MAOA (0.51) MAOACYP3A4SLC6A4MAOBHSD17B10
SCHEMBL18409933 0.79 MAOB (0.57) MAOACYP3A4SLC6A4CYP19A1MAOB
SCHEMBL4955280 0.78 DPP4 (0.44) MAOAMAOBALDH1A1KMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US disclosed
EP-1446110-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES Structural Bioinformatics Inc. (US) 2004-08-18 EP disclosed
WO-2003032916-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES STRUCTURAL BIOINFORMATICS INC. (US) 2003-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases PTPRS, PTPRJ, PTPRCAP MAOA 4410/4885TAAR1 2141/4885CYP3A4 4650/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.